Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes

Tatjana Nikolic, Jaap J Zwaginga, Bas S Uitbeijerse, Nicky J Woittiez, Eelco J de Koning, Henk-Jan Aanstoot, Bart O Roep

Research output: Contribution to journal/periodicalArticleScientificpeer-review

55 Citations (Scopus)
Original languageEnglish
Pages (from-to)470-472
Number of pages3
JournalThe Lancet Diabetes & Endocrinology
Volume8
Issue number6
DOIs
Publication statusPublished - Jun 2020

Keywords

  • Autoimmunity/immunology
  • Dendritic Cells/immunology
  • Diabetes Mellitus, Type 1/immunology
  • Erythema/etiology
  • Feasibility Studies
  • Humans
  • Immune Tolerance
  • Immunotherapy/adverse effects
  • Injections, Intradermal
  • Insulin-Secreting Cells/immunology
  • Leukapheresis
  • Placebos
  • Proinsulin/administration & dosage
  • Prospective Studies

Cite this